Free Trial

Humana (HUM) Competitors

Humana logo
$457.15 +7.15 (+1.59%)
As of 10:46 AM Eastern
This is a fair market value price provided by Massive. Learn more.

HUM vs. CI, CNC, ELV, HCA, and MOH

Should you buy Humana stock or one of its competitors? Humana's main competitors and comparable companies include Cigna Group (CI), Centene (CNC), Elevance Health (ELV), HCA Healthcare (HCA), and Molina Healthcare (MOH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Humana compare to Cigna Group?

Cigna Group (NYSE:CI) and Humana (NYSE:HUM) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, risk, institutional ownership, profitability and valuation.

Cigna Group has a beta of 0.25, indicating that its stock price is 75% less volatile than the broader market. Comparatively, Humana has a beta of 0.65, indicating that its stock price is 35% less volatile than the broader market.

Cigna Group has a net margin of 2.09% compared to Humana's net margin of 0.81%. Cigna Group's return on equity of 19.57% beat Humana's return on equity.

Company Net Margins Return on Equity Return on Assets
Cigna Group2.09% 19.57% 5.35%
Humana 0.81%8.50%2.90%

In the previous week, Humana had 6 more articles in the media than Cigna Group. MarketBeat recorded 35 mentions for Humana and 29 mentions for Cigna Group. Cigna Group's average media sentiment score of 0.69 beat Humana's score of 0.64 indicating that Cigna Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cigna Group
12 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive
Humana
10 Very Positive mention(s)
7 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Cigna Group has higher revenue and earnings than Humana. Cigna Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cigna Group$274.90B0.28$5.96B$22.6613.10
Humana$129.66B0.42$1.19B$10.2843.81

Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.1%. Humana pays an annual dividend of $3.54 per share and has a dividend yield of 0.8%. Cigna Group pays out 27.5% of its earnings in the form of a dividend. Humana pays out 34.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has increased its dividend for 5 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

87.0% of Cigna Group shares are owned by institutional investors. Comparatively, 92.4% of Humana shares are owned by institutional investors. 0.6% of Cigna Group shares are owned by company insiders. Comparatively, 0.2% of Humana shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Cigna Group presently has a consensus price target of $336.90, indicating a potential upside of 13.51%. Humana has a consensus price target of $476.52, indicating a potential upside of 5.80%. Given Cigna Group's higher probable upside, equities research analysts plainly believe Cigna Group is more favorable than Humana.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cigna Group
0 Sell rating(s)
8 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.64
Humana
1 Sell rating(s)
9 Hold rating(s)
21 Buy rating(s)
1 Strong Buy rating(s)
2.69

Summary

Cigna Group beats Humana on 12 of the 20 factors compared between the two stocks.

How does Humana compare to Centene?

Centene (NYSE:CNC) and Humana (NYSE:HUM) are both large-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, valuation, risk, media sentiment, dividends and analyst recommendations.

Humana has lower revenue, but higher earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Centene$194.78B0.18-$6.67B$2.9224.40
Humana$129.66B0.42$1.19B$10.2843.81

93.6% of Centene shares are owned by institutional investors. Comparatively, 92.4% of Humana shares are owned by institutional investors. 0.4% of Centene shares are owned by insiders. Comparatively, 0.2% of Humana shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Centene has a beta of 1.07, suggesting that its stock price is 7% more volatile than the broader market. Comparatively, Humana has a beta of 0.65, suggesting that its stock price is 35% less volatile than the broader market.

Humana has a net margin of 0.81% compared to Centene's net margin of 0.72%. Centene's return on equity of 12.15% beat Humana's return on equity.

Company Net Margins Return on Equity Return on Assets
Centene0.72% 12.15% 3.28%
Humana 0.81%8.50%2.90%

In the previous week, Humana had 26 more articles in the media than Centene. MarketBeat recorded 35 mentions for Humana and 9 mentions for Centene. Centene's average media sentiment score of 0.83 beat Humana's score of 0.64 indicating that Centene is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Centene
4 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Humana
10 Very Positive mention(s)
7 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Centene presently has a consensus price target of $73.80, indicating a potential upside of 3.60%. Humana has a consensus price target of $476.52, indicating a potential upside of 5.80%. Given Humana's stronger consensus rating and higher probable upside, analysts clearly believe Humana is more favorable than Centene.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Centene
1 Sell rating(s)
11 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.38
Humana
1 Sell rating(s)
9 Hold rating(s)
21 Buy rating(s)
1 Strong Buy rating(s)
2.69

Summary

Humana beats Centene on 10 of the 17 factors compared between the two stocks.

How does Humana compare to Elevance Health?

Humana (NYSE:HUM) and Elevance Health (NYSE:ELV) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

92.4% of Humana shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.2% of Humana shares are owned by insiders. Comparatively, 0.3% of Elevance Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Humana currently has a consensus target price of $476.52, indicating a potential upside of 5.80%. Elevance Health has a consensus target price of $456.48, indicating a potential upside of 6.28%. Given Elevance Health's higher probable upside, analysts plainly believe Elevance Health is more favorable than Humana.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Humana
1 Sell rating(s)
9 Hold rating(s)
21 Buy rating(s)
1 Strong Buy rating(s)
2.69
Elevance Health
0 Sell rating(s)
7 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.68

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 0.8%. Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.6%. Humana pays out 34.4% of its earnings in the form of a dividend. Elevance Health pays out 29.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 14 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Elevance Health has a net margin of 2.55% compared to Humana's net margin of 0.81%. Elevance Health's return on equity of 14.97% beat Humana's return on equity.

Company Net Margins Return on Equity Return on Assets
Humana0.81% 8.50% 2.90%
Elevance Health 2.55%14.97%5.31%

In the previous week, Humana had 20 more articles in the media than Elevance Health. MarketBeat recorded 35 mentions for Humana and 15 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.21 beat Humana's score of 0.64 indicating that Elevance Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Humana
10 Very Positive mention(s)
7 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Elevance Health
11 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Humana has a beta of 0.65, indicating that its stock price is 35% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.63, indicating that its stock price is 37% less volatile than the broader market.

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Humana$129.66B0.42$1.19B$10.2843.81
Elevance Health$199.13B0.47$5.66B$23.4518.32

Summary

Elevance Health beats Humana on 13 of the 20 factors compared between the two stocks.

How does Humana compare to HCA Healthcare?

HCA Healthcare (NYSE:HCA) and Humana (NYSE:HUM) are both large-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

HCA Healthcare pays an annual dividend of $3.12 per share and has a dividend yield of 0.6%. Humana pays an annual dividend of $3.54 per share and has a dividend yield of 0.8%. HCA Healthcare pays out 10.3% of its earnings in the form of a dividend. Humana pays out 34.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. HCA Healthcare has raised its dividend for 6 consecutive years.

HCA Healthcare has a beta of 1.11, meaning that its stock price is 11% more volatile than the broader market. Comparatively, Humana has a beta of 0.65, meaning that its stock price is 35% less volatile than the broader market.

HCA Healthcare has higher earnings, but lower revenue than Humana. HCA Healthcare is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HCA Healthcare$75.60B1.38$6.78B$30.1816.53
Humana$129.66B0.42$1.19B$10.2843.81

62.7% of HCA Healthcare shares are held by institutional investors. Comparatively, 92.4% of Humana shares are held by institutional investors. 1.5% of HCA Healthcare shares are held by company insiders. Comparatively, 0.2% of Humana shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Humana had 4 more articles in the media than HCA Healthcare. MarketBeat recorded 35 mentions for Humana and 31 mentions for HCA Healthcare. Humana's average media sentiment score of 0.64 beat HCA Healthcare's score of 0.35 indicating that Humana is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
HCA Healthcare
8 Very Positive mention(s)
1 Positive mention(s)
10 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Humana
10 Very Positive mention(s)
7 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

HCA Healthcare has a net margin of 8.61% compared to Humana's net margin of 0.81%. Humana's return on equity of 8.50% beat HCA Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
HCA Healthcare8.61% -198.52% 10.81%
Humana 0.81%8.50%2.90%

HCA Healthcare presently has a consensus price target of $480.13, suggesting a potential downside of 3.75%. Humana has a consensus price target of $476.52, suggesting a potential upside of 5.80%. Given Humana's stronger consensus rating and higher possible upside, analysts plainly believe Humana is more favorable than HCA Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HCA Healthcare
1 Sell rating(s)
7 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
2.63
Humana
1 Sell rating(s)
9 Hold rating(s)
21 Buy rating(s)
1 Strong Buy rating(s)
2.69

Summary

Humana beats HCA Healthcare on 11 of the 20 factors compared between the two stocks.

How does Humana compare to Molina Healthcare?

Molina Healthcare (NYSE:MOH) and Humana (NYSE:HUM) are both large-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk.

Humana has a net margin of 0.81% compared to Molina Healthcare's net margin of -0.11%. Humana's return on equity of 8.50% beat Molina Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Molina Healthcare-0.11% 2.50% 0.65%
Humana 0.81%8.50%2.90%

98.5% of Molina Healthcare shares are held by institutional investors. Comparatively, 92.4% of Humana shares are held by institutional investors. 1.4% of Molina Healthcare shares are held by insiders. Comparatively, 0.2% of Humana shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Molina Healthcare has a beta of 0.74, indicating that its share price is 26% less volatile than the broader market. Comparatively, Humana has a beta of 0.65, indicating that its share price is 35% less volatile than the broader market.

Humana has higher revenue and earnings than Molina Healthcare. Molina Healthcare is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Molina Healthcare$45.43B0.24$472M-$0.96N/A
Humana$129.66B0.42$1.19B$10.2843.81

Molina Healthcare currently has a consensus target price of $213.88, suggesting a potential upside of 2.15%. Humana has a consensus target price of $476.52, suggesting a potential upside of 5.80%. Given Humana's stronger consensus rating and higher probable upside, analysts clearly believe Humana is more favorable than Molina Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Molina Healthcare
2 Sell rating(s)
13 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.06
Humana
1 Sell rating(s)
9 Hold rating(s)
21 Buy rating(s)
1 Strong Buy rating(s)
2.69

In the previous week, Humana had 9 more articles in the media than Molina Healthcare. MarketBeat recorded 35 mentions for Humana and 26 mentions for Molina Healthcare. Humana's average media sentiment score of 0.64 beat Molina Healthcare's score of -0.08 indicating that Humana is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Molina Healthcare
5 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Humana
10 Very Positive mention(s)
7 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Humana beats Molina Healthcare on 13 of the 17 factors compared between the two stocks.

Get Humana News Delivered to You Automatically

Sign up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HUM vs. The Competition

MetricHumanaHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$55.02B$10.96B$7.91B$23.42B
Dividend Yield0.79%2.54%2.47%3.78%
P/E Ratio44.5736.3634.5229.71
Price / Sales0.422.058.153.10
Price / Cash18.7023.2821.0215.64
Price / Book3.113.994.754.08
Net Income$1.19B$335.01M$3.52B$1.08B
7 Day Performance8.20%-3.03%-3.82%-2.15%
1 Month Performance10.99%-0.27%-2.07%-0.27%
1 Year Performance93.35%21.15%0.68%6.58%

Humana Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HUM
Humana
3.9635 of 5 stars
$457.15
+1.6%
$482.96
+5.6%
+90.1%$54.89B$129.66B44.4667,060
CI
Cigna Group
4.7896 of 5 stars
$295.37
+0.6%
$336.20
+13.8%
+10.1%$78.05B$274.90B13.0467,700
CNC
Centene
3.9441 of 5 stars
$68.64
-1.6%
$73.80
+7.5%
+95.7%$33.98B$203.90B23.5161,100
ELV
Elevance Health
4.7578 of 5 stars
$417.73
-1.9%
$456.48
+9.3%
+31.8%$90.26B$199.13B17.8197,100
HCA
HCA Healthcare
3.597 of 5 stars
$504.85
+2.0%
$480.13
-4.9%
+5.6%$105.46B$78.70B16.73320,000

Related Companies and Tools


This page (NYSE:HUM) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners